Combination of | |
---|---|
Artesunate | artemisinin |
Mefloquine | antimalarial |
Clinical data | |
ATC code | |
Identifiers | |
CAS Number | |
CompTox Dashboard ( EPA) |
Artesunate/mefloquine is a medication used to treat malaria. [1] It is a fixed dose combination of artesunate and mefloquine. [1] Specifically it is recommended to treat uncomplicated falciparum malaria. [2] It is taken by mouth. [1]
Side effects are similar to the medications being used separately. [2] Use is recommended as it decreases the possibility of either medications being used alone. [2] Dose forms appropriate for children are also available. [2]
Artesunate/mefloquine came into commercial use in 2008. [3] It is on the World Health Organization's List of Essential Medicines. [1] It is approved for medical use in Brazil, India, and Malaysia. [2] It is not commercially available in the United States. [4]
Artesunate/mefloquine is a recommended treatment in Southeast Asia while in Africa artesunate/amodiaquine, artemether/lumefantrine, artesunate/sulfadoxine/pyrimethamine are often preferred. [5]